Firms

Frist Cressey Ventures

Frist Cressey Ventures

3810 Bedford Avenue, Suite200, Nashville, Tennessee37215, United States · New York, United States

fcventures.com

Frist Cressey Ventures (FCV) is a healthcare venture capital firm founded in2016 by Bill Frist and Bryan Cressey, with offices in Nashville and New York. The regulated manager identity is Frist Cressey Ventures Management, LLC, SEC exempt reporting adviser CRD299793; this is distinct from separate healthcare private equity firm Cressey & Company. FCV backs early-stage technology and technology-enabled services that improve care delivery, clinical outcomes, access, affordability and healthcare system integration. Its2026 Fund IV strategy explicitly includes AI-native healthcare businesses. Sourced relationships include Qualified Health, Ambience Healthcare, Carta Healthcare, Blackbird Health and Modicus Prime, covering enterprise healthcare AI, clinical workflow automation, mental health care and pharmaceutical AI compliance. The current public manager roster lists20 people, including co-founder/managing partner Bill Frist, co-founder/senior adviser Bryan Cressey, managing partner Navid Farzad, partner Olivia Capra, partner/COO J. Mark Tipps and operating partner Harrison Frist, who joined inApril2026. The FCV Collective is an external healthcare leadership programme; its cohort members are not imported as employees. The issuer announced an actual oversubscribed USD425M Fund IV final close on18February2026. Parallel LP, QP and feeder vehicles are distinguished from the family aggregate; no amount is assigned to each vehicle without a verified allocation. Other current private vehicles are documented by the March2026 manager Form ADV, with unverified final fund-close sizes left empty. Prior institutional and personal investor records are preserved.

Founded
2016
Type
Venture capital

Funds9

  • Frist Cressey Ventures Fund IV (parallel LP and QP family)$425M

    Actual oversubscribed USD425M aggregate final close announced by the firm on18February2026. One family total spanning parallel legal LP and QP vehicles; no duplicate425M allocated to each individual entity. This is a cash fund close, separate from the firm’s AUM or2025 offering target.

  • FRIST CRESSEY CO-INVEST, LLC—

    Current exact legal private vehicle documented by Frist Cressey Ventures Management, LLC’s17March2026 Form ADV. Parallel family funds and QP aggregator feeders are separately identified. No verified vehicle-specific final close amount/day is asserted; NAV, offering targets, interim subscriptions and manager AUM are not treated as closed fund size. The aggregate2026 Fund IV425MUSD final close is recorded once in the separate family record.

  • FRIST CRESSEY VENTURES FUND II QP, LP—

    Current exact legal private vehicle documented by Frist Cressey Ventures Management, LLC’s17March2026 Form ADV. Parallel family funds and QP aggregator feeders are separately identified. No verified vehicle-specific final close amount/day is asserted; NAV, offering targets, interim subscriptions and manager AUM are not treated as closed fund size. The aggregate2026 Fund IV425MUSD final close is recorded once in the separate family record.

  • FRIST CRESSEY VENTURES FUND II, LP—

    Current exact legal private vehicle documented by Frist Cressey Ventures Management, LLC’s17March2026 Form ADV. Parallel family funds and QP aggregator feeders are separately identified. No verified vehicle-specific final close amount/day is asserted; NAV, offering targets, interim subscriptions and manager AUM are not treated as closed fund size. The aggregate2026 Fund IV425MUSD final close is recorded once in the separate family record.

  • FRIST CRESSEY VENTURES FUND III QP, LP—

    Current exact legal private vehicle documented by Frist Cressey Ventures Management, LLC’s17March2026 Form ADV. Parallel family funds and QP aggregator feeders are separately identified. No verified vehicle-specific final close amount/day is asserted; NAV, offering targets, interim subscriptions and manager AUM are not treated as closed fund size. The aggregate2026 Fund IV425MUSD final close is recorded once in the separate family record.

  • FRIST CRESSEY VENTURES FUND III, LP—

    Current exact legal private vehicle documented by Frist Cressey Ventures Management, LLC’s17March2026 Form ADV. Parallel family funds and QP aggregator feeders are separately identified. No verified vehicle-specific final close amount/day is asserted; NAV, offering targets, interim subscriptions and manager AUM are not treated as closed fund size. The aggregate2026 Fund IV425MUSD final close is recorded once in the separate family record.

  • FRIST CRESSEY VENTURES FUND IV QP AGGREGATOR 1, LP—

    Current exact legal private vehicle documented by Frist Cressey Ventures Management, LLC’s17March2026 Form ADV. Parallel family funds and QP aggregator feeders are separately identified. No verified vehicle-specific final close amount/day is asserted; NAV, offering targets, interim subscriptions and manager AUM are not treated as closed fund size. The aggregate2026 Fund IV425MUSD final close is recorded once in the separate family record.

  • FRIST CRESSEY VENTURES FUND IV QP, LP—

    Current exact legal private vehicle documented by Frist Cressey Ventures Management, LLC’s17March2026 Form ADV. Parallel family funds and QP aggregator feeders are separately identified. No verified vehicle-specific final close amount/day is asserted; NAV, offering targets, interim subscriptions and manager AUM are not treated as closed fund size. The aggregate2026 Fund IV425MUSD final close is recorded once in the separate family record.

Team

Operations and support

Bill FristBill FristCo-Founder & Managing Partner
Bryan CresseyBryan CresseyCo-Founder & Senior Advisor
Caroline YoungHead of Partnership Development
Chloe CoulterDirector of Value Creation
Derek DedekerPrincipal
Harrison FristHarrison FristOperating Partner
J. Mark TippsPartner & COO
Jamie KuntzAssociate, Partnership Development
Lauren MartinAdministrative Assistant
Lydia WittyInvestment Associate
Matt SchappellPrincipal
Navid FarzadNavid FarzadManaging Partner
Olivia CapraPartner
Owen McGrathDirector of Finance and Operations
Tommaso AuerbachSenior Associate
Traci FewManager, Personnel and Operations
Whit EmersonInvestment Associate
William TrapnellSenior Associate
Zach JohnsonChief Financial Officer
Zeena JoharZeena JoharEntrepreneur in Residence

Co-investing

AlleyCorp
Town Hall Ventures
Andreessen Horowitz
Vineeta Agarwala
Foresite Capital

Investments

$4M2026-05-06Modicus PrimeFrist Cressey Ventures, Silverton Partners, Oncology Ventures
$—2026-09-02Thyme CareMorgan Health, Vineeta Agarwala, Humana, CVS Health Ventures, AlleyCorp, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, Andreessen Horowitz, HealthQuest Capital
$11M2026-05-12Knit Health TechnologiesUncork Capital, Frist Cressey Ventures, Coalition Operators, Moxxie Ventures
$125M2026-03-25Qualified HealthNEA (New Enterprise Associates), Transformation Capital, Cathay Innovation, Menlo Ventures, SignalFire, Frist Cressey Ventures, Flare Capital Partners, Healthier Capital, Town Hall Ventures, Intermountain Health, GreatPoint Ventures
$60M2026-02-04Chamber CardioGeneral Catalyst, Company Ventures, AlleyCorp, American Family Ventures, Frist Cressey Ventures, Healthworx
$97M2025-09-25Thyme CareVineeta Agarwala, Morgan Health, CVS Health Ventures, Foresite Capital, Andreessen Horowitz, Concord Health Partners, Town Hall Ventures, AlleyCorp, Frist Cressey Ventures, Humana, Memorial Hermann Health System
$—2025-01-08Qualified HealthSignalFire, Healthier Capital, Town Hall Ventures, Frist Cressey Ventures, Intermountain Health, Flare Capital Partners, Frank Williams, Justin Kan, Bill Veghte, Varsha Rao
$14M2024-08-13MD AllyGeneral Catalyst, Alumni Ventures, Techstars, SE Ventures, Frist Cressey Ventures, Hemant Taneja
$55M2024-07-16Thyme CareVineeta Agarwala, Concord Health Partners, CVS Health Ventures, Town Hall Ventures, Andreessen Horowitz, AlleyCorp, Echo Health Ventures, Frist Cressey Ventures, Foresite Capital
$17M2024-02-21Blackbird HealthDefine Ventures, Frist Cressey Ventures, GreyMatter Capital